{"answers":{"affected":"It affects 1 product.","exploited":"There is no known exploitation of CVE-2024-2275 in the wild and no public exploit code.","fix":"No fix has been published for CVE-2024-2275 yet. Limit exposure of the affected software until one is available.","what":"CVE-2024-2275 is a low-severity cross-site scripting vulnerability in Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software, published on 8 Mar 2024. An attacker needs administrator access to exploit it, and only if a user opens a file or follows a link."},"fix_prompt":"Check this codebase for CVE-2024-2275 and fix it if it is affected.\n\nWhat it is: CVE-2024-2275 is a low-severity cross-site scripting vulnerability in Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software, published on 8 Mar 2024. An attacker needs administrator access to exploit it, and only if a user opens a file or follows a link.\nExploitation: There is no known exploitation of CVE-2024-2275 in the wild and no public exploit code.\n\nAffected product: Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software. No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2024-2275/ (Markdown: https://insights.sbomify.com/CVE-2024-2275/index.md)","id":"CVE-2024-2275","markdown":"https://insights.sbomify.com/CVE-2024-2275/index.md","name":"CVE-2024-2275","record":{"aliases":["GHSA-8c2p-fm7f-34m4"],"analysis":{"component_type":"web_application","fix_type":"no_fix_stated","impacts":["code_execution","account_takeover"],"network_reachable":"yes","non_default_config":false,"product_category":"Gynaecology consultation software","requires_auth":"high_privilege","summary":"Remote attackers can inject malicious scripts via patient prescription fields in Bdtask G-Prescription software, potentially compromising user sessions.","user_interaction":"required","vuln_class":"xss"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"VulDB","cpe":[{"product":"g-prescription_gynaecology_\\\u0026_obs_consultation","vendor":"bdtask"}],"cvss":{"score":2.4,"severity":"low","source":"cna","vector":"CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N","version":"3.1"},"cwes":[{"id":"CWE-79","name":"Improper Neutralization of Input During Web Page Generation"}],"description":"A vulnerability, which was classified as problematic, was found in Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software 1.0. Affected is an unknown function of the component OBS Patient/Gynee Prescription. The manipulation of the argument Patient Title/Full Name/Address/Cheif Complain/LMP/Menstrual Edd/OBS P/OBS Alc/Medicine Name/Medicine Type/Ml/Dose/Days/Comments/Template Name leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. The identifier of this vulnerability is VDB-256044. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"none_known"},"has_fix":null,"headline":"Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software OBS Patient/Gynee Prescription cross site scripting","id":"CVE-2024-2275","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"xss","year":"2024"},"n_packages":0,"n_references":3,"next":{"headline":"Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software Edit Venue Page cross site scripting","id":"CVE-2024-2276"},"packages":[],"prev":{"headline":"Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software Prescription Dashboard Index cross site scripting","id":"CVE-2024-2274"},"products":["G-Prescription Gynaecology \u0026 OBS Consultation Software"],"published":"2024-03-08","related":[{"cvss_score":4.3,"headline":"Cross-site request forgery in G-Prescription Gynaecology \u0026 OBS Consultation Software","id":"CVE-2024-2277","kev_date_added":null,"published":"2024-03-08"},{"cvss_score":2.4,"headline":"Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software Prescription Dashboard Index cross site scripting","id":"CVE-2024-2274","kev_date_added":null,"published":"2024-03-08"},{"cvss_score":2.4,"headline":"Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software Edit Venue Page cross site scripting","id":"CVE-2024-2276","kev_date_added":null,"published":"2024-03-08"}],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"US public information, NVD API terms","name":"NVD"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":"no","exploitation":"none","technical_impact":"partial"},"state":"PUBLISHED","updated":"2024-08-01","vendors":["Bdtask"]},"summary":"Remote attackers can inject malicious scripts via patient prescription fields in Bdtask G-Prescription software, potentially compromising user sessions.","url":"https://insights.sbomify.com/CVE-2024-2275/"}